9021 Preliminary results of MAGE-A3 expression and baseline...

European Journal of Cancer Supplements 2009 / 9 Vol. 7; Iss. 2

9021 Preliminary results of MAGE-A3 expression and baseline demographic data from MAGRIT, a large phase III trial of MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic) in adjuvant NSCLC

Zielinski, M., Laskowski, U., Bieselt, R., Reck, M., Strausz, J., Perdeus, J., Park, K., Atanackovic, D., Debois, M., Debruyne, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71734-3
Date:
September, 2009
File:
PDF, 66 KB
english, 2009
Conversion to is in progress
Conversion to is failed